Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Parmax Pharma Ltd.

May 30, 12:51 BSE 31.00 (+ 0.84 2.79%)

Volume73

Prev. Close
30.16

Open Price
32.00

Today's Low / High

30.80 32.00

Bid. Price (Qty.)29.55 (10)

Offer Price (Qty.)
30.99 (43)

52 Wk Low / High

24.18 37.90

Parmax Pharma Ltd.is not traded in NSE

Standalone

(₹ in Crs.)

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	51.01	51.01	51.01	51.01	51.01

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	4.45	4.45	4.45	4.45	4.45
Total Share Capital	4.45	4.45	4.45	4.45	4.45

Reserves and Surplus	1.40	1.51	1.37	0.61	0.18
Total Reserves and Surplus	1.40	1.51	1.37	0.61	0.18
Total Shareholders Funds	5.86	5.96	5.82	5.06	4.64

NON-CURRENT LIABILITIES
Long Term Borrowings	4.48	4.52	5.43	5.03	5.26
Deferred Tax Liabilities [Net]	0.14	0.18	0.23	0.07	0.00
Total Non-Current Liabilities	4.62	4.70	5.66	5.11	5.26

CURRENT LIABILITIES
Trade Payables	4.66	5.52	9.92	9.92	9.19
Other Current Liabilities	1.50	0.86	0.49	0.24	0.32
Short Term Provisions	0.97	0.94	0.84	0.73	0.31
Total Current Liabilities	7.14	7.32	11.25	10.89	9.82

Total Capital And Liabilities	17.61	17.97	22.73	21.06	19.71

ASSETS
NON-CURRENT ASSETS
Tangible Assets	9.50	10.44	10.84	9.64	4.92
Capital Work-In-Progress	0.00	0.00	0.00	0.00	3.33
Fixed Assets	9.50	10.44	10.84	9.64	8.25
Non-Current Investments	0.00	0.00	0.20	0.20	0.20
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.08
Long Term Loans And Advances	0.19	0.18	0.16	0.20	0.17
Other Non-Current Assets	0.40	0.79	1.19	1.58	1.98
Total Non-Current Assets	10.08	11.42	12.39	11.62	10.68


CURRENT ASSETS
Inventories	4.31	2.85	3.95	2.72	3.97
Trade Receivables	0.62	0.68	1.65	3.30	1.15
Cash And Cash Equivalents	0.41	1.05	2.55	1.77	1.57
Short Term Loans And Advances	2.19	1.98	2.19	1.65	2.35
Total Current Assets	7.53	6.56	10.34	9.44	9.03

Total Assets	17.61	17.97	22.73	21.06	19.71

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	1.00	1.00	0.00	0.00	0.00

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00	0.00	0.20	0.20	0.20

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00
No. of Equity Shares (in Lacs)	51.01

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	4.45
Total Share Capital	4.45
Reserves and Surplus	1.40
Total Reserves and Surplus	1.40
Total Shareholders Funds	5.86
NON-CURRENT LIABILITIES
Long Term Borrowings	4.48
Deferred Tax Liabilities [Net]	0.14
Total Non-Current Liabilities	4.62
CURRENT LIABILITIES
Trade Payables	4.66
Other Current Liabilities	1.50
Short Term Provisions	0.97
Total Current Liabilities	7.14
Total Capital And Liabilities	17.61
ASSETS
NON-CURRENT ASSETS
Tangible Assets	9.50
Capital Work-In-Progress	0.00
Fixed Assets	9.50
Non-Current Investments	0.00
Deferred Tax Assets [Net]	0.00
Long Term Loans And Advances	0.19
Other Non-Current Assets	0.40
Total Non-Current Assets	10.08
CURRENT ASSETS
Inventories	4.31
Trade Receivables	0.62
Cash And Cash Equivalents	0.41
Short Term Loans And Advances	2.19
Total Current Assets	7.53
Total Assets	17.61
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	1.00
NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00